Harmony Biosciences Holdings (HRMY)
Operating profit margin
| Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | ||
|---|---|---|---|---|---|---|
| Operating income | US$ in thousands | 190,826 | 192,030 | 120,186 | 87,528 | 16,986 |
| Revenue | US$ in thousands | 714,734 | 548,499 | 419,060 | 255,101 | 134,691 |
| Operating profit margin | 26.70% | 35.01% | 28.68% | 34.31% | 12.61% |
December 31, 2024 calculation
Operating profit margin = Operating income ÷ Revenue
= $190,826K ÷ $714,734K
= 26.70%
Harmony Biosciences Holdings has shown fluctuations in its operating profit margin over the past five years. The operating profit margin increased from 12.61% on December 31, 2020, to 34.31% on December 31, 2021, indicating a significant improvement in profitability. However, there was a slight decrease to 28.68% on December 31, 2022, followed by a further increase to 35.01% on December 31, 2023. Subsequently, on December 31, 2024, the operating profit margin decreased to 26.70%.
The company experienced a notable improvement in profitability in the initial years, but this was followed by some fluctuations in the later years. It is crucial for Harmony Biosciences Holdings to monitor and control its operating expenses effectively to maintain a sustainable level of operating profit margin in the future.
Peer comparison
Dec 31, 2024